John Leonard - Quintiles Transnational Independent Director
Director
Dr. John M. Leonard, M.D. is Independent Director of Company. Since July 2014, Dr. Leonard serves as Executive Vice President, RD, at Intellia Therapeutics, Inc., a biotechnology company involved in genebased therapy. Dr. Leonard previously served as the Chief Scientific Officer and Senior Vice President of Research and Development at AbbVie Inc., a global pharmaceutical company, from its spinout from Abbott Laboratories in January 2013 until retiring from those positions at the end of 2013. Prior to the formation of AbbVie, Dr. Leonard served as Senior Vice President of Global Pharmaceutical Research and Development at Abbott from 2008 to 2012. He has over 30 years of combined experience in medicine, research and management, including serving in various roles at Abbott beginning in 1992. Dr. Leonard also serves as a director of Chimerix, Inc. and Intellia Therapeutics, Inc. Dr. Leonard earned a Bachelors Degree in Biochemistry from the University of Wisconsin at Madison and a Doctorate in Medicine from Johns Hopkins University in Baltimore, MD. Dr. Leonard completed an Internship and Residency in Internal Medicine at Stanford University Hospital followed by a Postdoctoral Fellowship in Molecular Virology at the National Institute of Allergy and Infectious Diseases at the National Institutes of Health. Dr. Leonard serves as a member of the Audit Committee and as a member of the Nominating and Governance Committee. since 2015.
Age | 58 |
Tenure | 9 years |
Professional Marks | Ph.D |
Phone | 919-998-2000 |
Web | www.quintiles.com |
Quintiles Transnational Management Efficiency
The company has return on total asset of 4.03 % which means that for every 100 dollars spent on assets, it generated a profit of $4.03. This is acceptable considering the industry classification. Similarly, it shows a return on equity (ROE) of 1.89 %, implying that it made 1.89 on every $100 invested by shareholders. Quintiles Transnational's management efficiency ratios could be used to measure how well Quintiles Transnational manages its routine affairs as well as how well it operates its assets and liabilities.The company has accumulated 9.77 B in total debt with debt to equity ratio (D/E) of 130.0, indicating that it may be unable to produce cash to meet its debt commitments. Quintiles Transnational has a current ratio of 1.2, implying that it may have difficulties to pay its interest payments when they become due. Debt can assist Quintiles Transnational until it has trouble settling it off, either with new capital or with free cash flow. So, Quintiles Transnational's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Quintiles Transnational sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Quintiles to invest in growth at high rates of return. When we think about Quintiles Transnational's use of debt, we should always consider it together with cash and equity.
Similar Executives
Showing other executives | DIRECTOR Age | ||
Robert Jenkins | Acco Brands | 72 | |
Kathryn McCarthy | SEI Investments | 69 | |
Pradeep Jotwani | Acco Brands | 66 | |
Ben Veer | Relx PLC ADR | 67 | |
James Buzzard | Acco Brands | 65 | |
Kathleen Mazzarella | Waste Management | 61 | |
Wilmot Kidd | Silvercrest Asset Management | 76 | |
Andres Gluski | Waste Management | 63 | |
Alexander Whitelam | SEI Investments | N/A | |
Nick Luff | Relx PLC ADR | 49 | |
Michael Norkus | Acco Brands | 67 | |
George Bayly | Acco Brands | 73 | |
William Plummer | Waste Management | 62 | |
Graciela Monteagudo | Acco Brands | 54 | |
Kathleen Dvorak | Acco Brands | 64 | |
Frank Clark | Waste Management | 73 | |
Carol Mills | Relx PLC ADR | 63 | |
Hans Norkus | Acco Brands | 73 | |
Marike Lels | Relx PLC ADR | 61 | |
Adrian Hennah | Relx PLC ADR | 60 | |
Thomas Kroeger | Acco Brands | 72 |
Management Performance
Return On Equity | 1.89 | |||
Return On Asset | 4.03 |
Quintiles Transnational Leadership Team
Elected by the shareholders, the Quintiles Transnational's board of directors comprises two types of representatives: Quintiles Transnational inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Quintiles. The board's role is to monitor Quintiles Transnational's management team and ensure that shareholders' interests are well served. Quintiles Transnational's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Quintiles Transnational's outside directors are responsible for providing unbiased perspectives on the board's policies.
Thomas Pike, CEO and Director | ||
Ari Bousbib, Director | ||
Michael Evanisko, Independent Director | ||
Leonard Schaeffer, Independent Director | ||
James Erlinger, Executive Vice President General Counsel, Secretary | ||
John Danhakl, Director | ||
Richard Staub, President - Research and Development Solutions | ||
Michael McDonnell, CFO, Executive Vice President | ||
Kevin Gordon, COO | ||
John Leonard, Independent Director | ||
James Fasano, Director | ||
Jonathan Coslet, Director | ||
John Connaughton, Director | ||
Haiyuan Lo, Director | ||
Ronald Rittenmeyer, Director | ||
Dennis Gillings, Executive Chairman of the Board | ||
Todd Sisitsky, Director | ||
Jack Greenberg, Independent Director | ||
Kevin Knightly, President - Information and Technology Solutions |
Quintiles Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Quintiles Transnational a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 1.89 | |||
Return On Asset | 4.03 | |||
Profit Margin | 0.70 % | |||
Operating Margin | 10.90 % | |||
Current Valuation | 30.27 B | |||
Shares Outstanding | 211.31 M | |||
Shares Owned By Insiders | 5.72 % | |||
Shares Owned By Institutions | 90.97 % | |||
Number Of Shares Shorted | 8.91 M | |||
Price To Earning | 424.10 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Quintiles Transnational in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Quintiles Transnational's short interest history, or implied volatility extrapolated from Quintiles Transnational options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Quintiles Transnational using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Quintiles Stock
If you are still planning to invest in Quintiles Transnational check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Quintiles Transnational's history and understand the potential risks before investing.
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |